Vaccine And Immunotherapy Center
Biotechnology, 149 13th Street, Charlestown, Massachusetts, 01060, United States, 11-50 Employees
Phone Number: +14*********
Who is VACCINE AND IMMUNOTHERAPY CENTER
VIC explores and develops new ways to modulate the immune system for therapeutic benefit. Our approach is deeply collaborative and involves leveraging the expertise and direct involvement...
Read More
-
Headquarters: 149 13th Street, Charlestown, Massachusetts, 01060, United States
-
Employees: 11-50
-
Revenue: $250 Million to $500 Million
Industry: Biotechnology
SIC Code: 8011
|
NAICS Code: 621111 |
Show More
Does something look wrong? Fix it. | View contact records from VACCINE AND IMMUNOTHERAPY CENTER
Vaccine and Immunotherapy Center Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Vaccine and Immunotherapy Center
Answer: Vaccine and Immunotherapy Center's headquarters are located at 149 13th Street, Charlestown, Massachusetts, 01060, United States
Answer: Vaccine and Immunotherapy Center's phone number is +14*********
Answer: Vaccine and Immunotherapy Center's official website is https://advancingcures.org
Answer: Vaccine and Immunotherapy Center's revenue is $250 Million to $500 Million
Answer: Vaccine and Immunotherapy Center's SIC: 8011
Answer: Vaccine and Immunotherapy Center's NAICS: 621111
Answer: Vaccine and Immunotherapy Center has 11-50 employees
Answer: Vaccine and Immunotherapy Center is in Biotechnology
Answer: Vaccine and Immunotherapy Center contact info: Phone number: +14********* Website: https://advancingcures.org
Answer: VIC explores and develops new ways to modulate the immune system for therapeutic benefit. Our approach is deeply collaborative and involves leveraging the expertise and direct involvement of academic and industry scientists from US and abroad. We currently have nine products in our pipeline ranging from small molecule immune modulators for specific cancers through a vaccine in development for Q fever to a novel microencapsulant to enable allogeneic cell or tissue transplantation without immune suppression.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month